Democrats’ new logic on drug pricing: Developing slightly fewer medicines is OK if it means lower prices
(By Lev Facher for STAT) WASHINGTON — Democratic lawmakers in recent weeks have begun to advance an argument long seen
Read More(By Lev Facher for STAT) WASHINGTON — Democratic lawmakers in recent weeks have begun to advance an argument long seen
Read More(By Phil Galewitz for Kaiser Health News) Under pressure from the Republican-controlled Pennsylvania legislature to require Medicaid recipients to work
Read MoreMedicare Part D drug plans provide drug benefits to millions of seniors each year. But Part D plans often make
Read More(By JoNel Aleccia, Barbara Feder Ostrov, and Donna Gordon Blankinship for Kaiser Health News) When a long, black bus bearing
Read More(By Gretchen Jacobson, Meredith Freed, Anthony Damico, and Tricia Neuman for the Henry J. Kaiser Family Foundation) Medicare Advantage plans
Read More(By Damian Garde and Adam Feuerstein for STAT) Biogen’s decision to revisit a once-failed treatment for Alzheimer’s disease came as
Read More(Source – blog.ssa.gov/medicare) Social Security and Medicare are both programs that are household names, but do you know the true
Read More(By Blake Farmer for NPR) While thousands of cities and counties have banded together to sue opioid makers and distributors in
Read MoreThe Trump administration has required hospitals to publicly disclose their prices also known as “chargemasters.” Although hospitals chargemaster lists the
Read MoreIf you don’t sign up for Medicare Part B during your seven-month initial enrollment period, you can sign up during
Read More